Clearance Summary
Natus Quantum received FDA 510(k) clearance under submission number K180181, sponsored by Natus Medical Incorporated Dba Excel_Tech Ltd. (Xltek). The device was reviewed via the Special premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2018-02-22.
- Submission: K180181
- Applicant / Sponsor: Natus Medical Incorporated Dba Excel_Tech Ltd. (Xltek)
- Clearance pathway: Special
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1400
- Decision date: 2018-02-22
Classification & Regulation
This clearance is catalogued under FDA product code GWQ and 21 CFR 882.1400, within the Neurology review panel as a Class II device.